Investing.com - Valeo Pharma reported on Tuesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Valeo Pharma announced earnings per share of C$-0.055 on revenue of C$6.1M. Analysts polled by Investing.com EPS of C$-0.055 on revenue of C$6M.
Valeo Pharma 's are down 23.13% and is trading at C$0.58 , still down 40.21% from its 52 week high of C$0.97 set on Thursday, October 7, 2021.
Valeo Pharma follows other major Healthcare sector earnings this month
Valeo Pharma's report follows an earnings missed by Cresco Labs on Wednesday, August 17, 2022, who reported EPS of C$-0.02 on revenue of C$218.23M, EPS of C$-0.0161 on revenue of C$218.27M.
Jushi Holdings had missed expectations on Monday, August 29, 2022 with second quarter EPS of C$-0.15 on revenue of C$72.8M, for EPS of C$-0.0932 on revenue of C$69.15M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar